“Shadow Trading” Becomes Insider Trading
Reynolds Holding
MARCH 28, 2022
an oncology-focused biopharmaceutical company. The SEC’s complaint deemed him an “expert in the biopharmaceutical industry,” based on his undergraduate and graduate science degrees, a top-school MBA, and relevant work experience in investment banking and business development. was imminent. percent premium to market and a 69.8
Let's personalize your content